Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders

Volume: 7, Issue: 5, Pages: e787 - e787
Published: Jun 4, 2020
Abstract
Objective Disease-modifying drugs (DMDs) may alter the immune status and thus increase the susceptibility to coronavirus disease 2019 (COVID-19) in patients with MS or neuromyelitis optica spectrum disorders (NMOSD). However, evidence supporting this notion is currently lacking. In this study, we conducted a survey on the risk of COVID-19 in patients with MS and NMOSD. Methods The survey was conducted through the Chinese Medical Network for...
Paper Details
Title
Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders
Published Date
Jun 4, 2020
Volume
7
Issue
5
Pages
e787 - e787
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.